Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1980 1
1990 1
1999 1
2001 1
2002 3
2003 6
2004 1
2005 13
2006 7
2007 19
2008 22
2009 20
2010 1
2011 3
2012 2
2013 3
2014 1
2015 3
2016 1
2017 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 17699475

103 results
Results by year
Filters applied: . Clear all
Page 1
Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC; PKC-DRS and PKC-DRS2 Study Groups. Aiello LP, et al. Retina. 2011 Nov;31(10):2084-94. doi: 10.1097/IAE.0b013e3182111669. Retina. 2011. PMID: 21862954 Clinical Trial.
103 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page